Robert Kang
Director of Finance/CFO bei ALBERT LABS INTERNATIONAL CORP.
Profil
Robert Kang is currently the Director & Chief Financial Officer at Albert Labs, Inc. and the Chief Financial Officer & Director at Albert Labs International Corp.
He previously worked as a Listings Director at TSX Venture Exchange, Inc.
Aktive Positionen von Robert Kang
| Unternehmen | Position | Beginn |
|---|---|---|
| ALBERT LABS INTERNATIONAL CORP. | Director of Finance/CFO | - |
Albert Labs, Inc.
 Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The private company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Director of Finance/CFO | - |
Ehemalige bekannte Positionen von Robert Kang
| Unternehmen | Position | Ende |
|---|---|---|
TSX Venture Exchange, Inc.
 TSX Venture Exchange, Inc. Investment ManagersFinance TSX Venture Exchange, Inc. provides capital and financial services to early stage companies. It offers an access to capital and a market for making venture investments. The firm also provides corporate finance, business development and compliance, and disclosure services. The company was founded on November 29, 1999 and is headquartered in Calgary, Canada. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALBERT LABS INTERNATIONAL CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
TSX Venture Exchange, Inc.
TSX Venture Exchange, Inc. Investment ManagersFinance TSX Venture Exchange, Inc. provides capital and financial services to early stage companies. It offers an access to capital and a market for making venture investments. The firm also provides corporate finance, business development and compliance, and disclosure services. The company was founded on November 29, 1999 and is headquartered in Calgary, Canada. | Finance |
Albert Labs, Inc.
Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The private company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Health Services |
